Clinical Trial Update: Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating reduced-dose radiotherapy for indolent B-cell non-Hodgkin lymphoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent B-cell Non-hodgkin Lymphoma

Snippet

Sponsor: Mayo Clinic | Conditions: Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma | Phase 2 | Status: RECRUITING